Among the five important variables identified in the random survival forest analysis, the MGMT promoter methylation status and TERT promoter mutation status are key molecular tumor markers of GBM.6 We analyzed the relationship between the MGMT promoter methylation status and the survival benefit associated with the TERT promoter mutation status. Here, TERT is linked to glioblastoma.